Possibly, in type 2 diabetes, the aforementioned pro-inflammatory state may overrule the suppressive effect of hyperinsulinaemia, ultimately leading to higher FGF23 levels overall. This evidence concerns the gene FGF23 and type 2 diabetes mellitus.